Melosus 1,5 mg/ml

Melosus 1.5 mg/ml is an analgesic and anti-inflammatory veterinary medicinal product for dogs. Melosus 1.5 mg/ml is one of the veterinary medicinal products that can only be obtained from a veterinarian or from a pharmacy on prescription from a veterinarian (UDA).

Melosus 1.5 mg/ml has the registration number:

The Netherlands:   REG NL 106874
Belgium: EU/2/10/116/005 (10 ml)
  EU/2/10/116/001 (25 ml)
  EU/2/10/116/002 (50 ml)
  EU/2/10/116/003 (125 ml)

Indication

  • Relief of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

Contraindication

  • Do not use in pregnant or lactating animals.
  • Not for use in dogs suffering from gastrointestinal disorders such as irritation and bleeding, impaired liver, heart or kidney function and clotting disorders.
  • Do not use in case of hypersensitivity to the active substance or to any of the excipients.
  • Do not use in dogs under 6 weeks of age.

Dosage

Melosus 1.5 mg/ml is an oral suspension and should be mixed with food or administered directly into the mouth.

Initial treatment is a single oral dose of 0.2 mg meloxicam per kg body weight on the first day. Daily treatment should be continued at an interval of 24 hours with a maintenance oral dose of 0.1 mg meloxicam per kg body weight, once daily.

The longer treatment duration, after a clinical effect is observed (after ≥ 4 days), the dose of Melosus can be adjusted to the lowest effective individual dose. It should be borne in mind that the degree of pain and inflammation in chronic musculoskeletal disorders can vary over time.

Composition

Active ingredient: Meloxicam 1.5mg/ml
Excipient: Sodium benzoate 1.75 mg/ml

Melosus 1.5 mg/ml is available in 10 ml, 25 ml and 125 ml bottles.

Side effects

Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have been reported occasionally. In very rare cases, bloody diarrhoea, vomiting blood, gastrointestinal ulceration and elevated liver enzymes have been reported. These side effects usually occur within the first week of treatment and in most cases are transient and disappear after treatment is discontinued, but in very rare cases can be serious or fatal. If side effects occur, treatment should be discontinued.

The frequency of side effects is defined as follows:

  • Very common (more than 1 in 10 animals treated show side effect(s))
  • Common (more than 1 but less than 10 out of 100 animals treated)
  • Uncommon (more than 1 but less than 10 in 1,000 animals treated)
  • Rare (more than 1 but less than 10 animals in 10,000 animals treated)
  • Very rare (less than 1 in 10,000 animals treated, including isolated reports)

Leaflet

Download the leaflet.

Download PDF